Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Armour Thyroid 60mg (1 grain) tablets
0602010Z0BBACAB
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 320 |
|
Armour Thyroid 30mg (half grain) tablets
0602010Z0BBABAA
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 137 |
|
Armour Thyroid 15mg (quarter grain) tablets
0602010Z0BBAAAE
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 73 |
|
Armour Thyroid 90mg (1 and a half grains) tablets
0602010Z0BBAGAC
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 70 |
|
Armour Thyroid 120mg (2 grains) tablets
0602010Z0BBADAD
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | 54 |
|
Armour Thyroid 180mg (3 grains) tablets
0602010Z0BBAHAH
|
Armour | Levothyroxine sodium and liothyronine | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.